{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Krishna Institute of Medical Sciences Ltd
Krishna Institute of Medical Sciences Ltd is Rated Sell
Krishna Institute of Medical Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Krishna Institute of Medical Sciences Ltd: Valuation Shift Signals Price Attractiveness Change
Krishna Institute of Medical Sciences Ltd (KIMS) has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals a subtle but important adjustment in the stock’s price attractiveness amid a challenging market backdrop and evolving sector dynamics.
Krishna Institute of Medical Sciences Ltd Declines 2.90%: Valuation and Volatility Shape Weekly Moves
Krishna Institute of Medical Sciences Ltd (KIMS) closed the week ending 6 March 2026 at Rs.726.00, down 2.90% from the previous Friday’s close of Rs.747.70. This performance slightly outpaced the broader Sensex, which declined 3.00% over the same period. The week was marked by a sharp gap down opening on 2 March amid market concerns and a notable valuation reassessment on 4 March, both contributing to the stock’s volatile price action and cautious investor sentiment.
Krishna Institute of Medical Sciences Ltd is Rated Sell
Krishna Institute of Medical Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Krishna Institute of Medical Sciences Ltd: Valuation Shifts Signal Price Attractiveness Change
Krishna Institute of Medical Sciences Ltd (KIMS) has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals a subtle recalibration in the stock’s price attractiveness amid a challenging hospital sector landscape. Investors should weigh these valuation dynamics against the company’s operational performance and peer comparisons to assess its market positioning.
Krishna Institute of Medical Sciences Ltd Opens with Sharp Gap Down Amid Market Concerns
Krishna Institute of Medical Sciences Ltd (KIMS) commenced trading today with a significant gap down, opening at a price 11.88% lower than its previous close. This weak start reflects heightened market concerns, resulting in notable intraday volatility and a cautious trading environment for the hospital sector stock.
Krishna Institute of Medical Sciences Ltd: Valuation Shifts Signal Heightened Price Risk
Krishna Institute of Medical Sciences Ltd (KIMS) has seen a notable shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. With a price-to-earnings (P/E) ratio soaring to 100.45 and a price-to-book value (P/BV) of 12.93, investors are now faced with a more challenging price attractiveness scenario compared to both historical averages and peer benchmarks within the hospital sector.
Krishna Institute of Medical Sciences Ltd is Rated Sell
Krishna Institute of Medical Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with the latest insights into its performance and outlook.